{"id":"W3202234535","doi":"10.1056/nejmoa2105290","title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":683,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; National Center for Advancing Translational Sciences; Johns Hopkins Bloomberg School of Public Health; Irving Medical Center, Columbia University; University of California, San Diego; AstraZeneca; York University; Emory University; Universidad de Chile; University of Rochester; University of Vermont; University of Washington; Johns Hopkins University; U.S. Department of Health and Human Services; National Institutes of Health; Children's Mercy Hospital","keywords":"Phase (matter); Vaccination; Immune system; Immunogenicity; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05032354525739646,"score_gpt":0.3948834473271394,"score_spread":0.344559902069743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}